DOI: 10.1515/mr-2023-0024
Drug development accelerated by artificial intelligence
Zhengwei Xie1
Hao Li2
1.PKU International Cancer Institute and Departmaent of Pharmacology,School of Basic Medicine,Peking University,Beijing 100871,China;Peking University-Yunnan Baiyao International Medical Research Center,Peking University Health Science Center,Peking University,Beijing 100191,China2.Department of Biochemistry and Biophysics,University of California San Francisco,1700 4th Street,San Francisco,CA 94143,USA
摘要：The development of biopharmaceuticals,driven by ad-vances in molecular cell biology,has accelerated in the past few decades.However,this development presents a paradox,namely,that highly developed biotechnology has led to lower success rates in clinical trials and higher costs in developing individual drugs.This huge obstacle has made drug development the exclusive privilege oflarge companies and has limited opportunities for small companies to develop advanced drugs.There is also a huge difference between developed and developing countries in terms of their capacity for pharmaceutical research and development(R&D),and high barriers limit the development of innovative drugs in developing countries.
机标关键词：developmentintelligenceacceleratedartificialdrug
论文发表日期：2023-06-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 193-194 )